Skip to main navigation Skip to search Skip to main content

Safety and Pharmacokinetics of SRN001, a Novel siRNA Drug Targeting Amphiregulin via the SAMiRNA Platform

Press/Media

Period2026.04.21

Media coverage

1

Media coverage